WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006126673) COMBINED DRUG FOR TREATING DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/126673    International Application No.:    PCT/JP2006/310550
Publication Date: 30.11.2006 International Filing Date: 26.05.2006
IPC:
A61K 31/427 (2006.01), A61K 45/00 (2006.01), A61P 3/10 (2006.01), A61P 5/50 (2006.01), A61P 43/00 (2006.01)
Applicants: DAIICHI SANKYO COMPANY, LIMITED [JP/JP]; 3-5-1, Nihonbashi Honcho Chuo-ku Tokyo 103-8426 (JP) (For All Designated States Except US).
NAKASHIMA, Ryutaro; (For US Only).
OGAWA, Junko; (For US Only).
OKUNO, Akira; (For US Only)
Inventors: NAKASHIMA, Ryutaro; .
OGAWA, Junko; .
OKUNO, Akira;
Agent: YAGUCHI, Toshiaki; c/o Daiichi Sankyo Company, Limited 1-16-13, Kitaasai, Edogawa-ku Tokyo 1348630 (JP)
Priority Data:
2005-155174 27.05.2005 JP
Title (EN) COMBINED DRUG FOR TREATING DIABETES
(FR) MÉDICAMENT COMBINÉ POUR LE TRAITEMENT DU DIABÈTE
(JA) 組み合わせによる糖尿病治療薬
Abstract: front page image
(EN)It is intended to provide a medicinal composition (in an appropriate case, a remedy and/or a preventive for diabetes) containing a combination of a GLP-1 receptor activator with 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidin-2,4-dione, which is an agent improving insulin resistance, or a pharmacologically acceptable salt thereof.
(FR)La présente invention concerne une préparation thérapeutique (dans un cas approprié, une préparation prophylactique et/ou thérapeutique pour le traitement du diabète) qui contient une combinaison d'un activant du récepteur GLP-1 et de la 5-[4-(6-méthoxy-1-méthyl-1H-benzimidazol-2-ylméthoxy)benzyl]thiazolidin-2,4-dione, qui est un agent améliorant la résistance à l'insuline, ou d'un sel de qualité pharmacologique dudit composé.
(JA) 本発明は、GLP-1受容体活性化剤と、インスリン抵抗性改善剤である5-[4-(6-メトキシ-1-メチル-1H-ベンゾイミダゾール-2-イルメトキシ)ベンジル]チアゾリジン-2,4-ジオン又はその薬理上許容される塩とを組み合わせてなる医薬組成物(好適には糖尿病の治療薬及び/又は予防薬である。)を提供する。
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)